Equity · Healthcare
THC
NYSETenet Healthcare (THC)
This price chart is drawn by TradingView, from their own data, in an embed loaded from their servers. We hold too few licensed daily closes of our own for THC to draw a line in its place.
- Market cap
- 22.6B USD
- P/E (TTM)
- 8.2
- Revenue, year to Dec 2025
- 21.3B USD
- EPS, diluted, year to Dec 2025
- 15.49 USD
- 52-week range
- 161.36 USD – 292.21 USD
- Avg volume
- 55.1K
as of Nov 6, 2026
Have Tenet Healthcare (THC) insiders bought or sold shares recently?
THC has no Form 4 filing in the last 90 days, so there is no summary for that window. The most recent filings we hold are below, the newest dated 14 September 2026.
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 14 Sep 2026 | KERREY J ROBERTDirector | Sell | 12,010 | 3.2M USD |
| 10 Sep 2026 | MARK RICHARD JDirector | Sell | 10,000 | 2.6M USD |
| 02 Sep 2026 | West NadjaDirector | Sell | 1,152 | 298K USD |
| 31 Aug 2026 | Foo Lisa YEVP, Chief Operating Officer | Sell | 24,000 | 6.4M USD |
| 25 Aug 2026 | Sutaria SaumyaCEO | Sell | 50,000 | 13.7M USD |
| 24 Aug 2026 | HANEY CECIL DDirector | Sell | 1,300 | 361K USD |
| 24 Aug 2026 | Sutaria SaumyaCEO | Sell | 50,000 | 13.9M USD |
| 07 Aug 2026 | Romo TammyDirector | Sell | 2,500 | 652K USD |
| 06 Aug 2026 | Romo TammyDirector | Sell | 4,922 | 1.3M USD |
| 05 Aug 2026 | Blunt RoyDirector | Sell | 600 | 158K USD |
| 29 Jul 2026 | Foo Lisa YEVP, Chief Operating Officer | Sell | 10,000 | 2.6M USD |
| 27 Jul 2026 | Lynch Christopher S.Director | Sell | 3,837 | 934K USD |
| Sold | 26 open-market sales | 286,854 | $71.70M |
Showing the 12 most recent of 26 open-market trades in this window. The figures above count all of them.
47 other filings: grants, exercises, tax withholding and transfers, not trades
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 28 Aug 2026 | HANEY CECIL DDirector | Gift | 150 | |
| 22 May 2026 | BIERMAN JAMES LDirector | Option exercise | 1,333 | |
| 22 May 2026 | Lynch Christopher S.Director | Option exercise | 1,333 | |
| 22 May 2026 | West NadjaDirector | Option exercise | 1,333 | |
| 22 May 2026 | West NadjaDirector | Other | 493 | 86K USD |
| 22 May 2026 | Romo TammyDirector | Option exercise | 1,333 | |
| 22 May 2026 | Romo TammyDirector | Other | 493 | 86K USD |
| 22 May 2026 | FISHER RICHARD WDirector | Option exercise | 1,333 | |
| 22 May 2026 | FISHER RICHARD WDirector | Other | 493 | 86K USD |
| 22 May 2026 | Fitzgerald MeghanDirector | Option exercise | 1,333 | |
| 22 May 2026 | Fitzgerald MeghanDirector | Other | 493 | 86K USD |
| 22 May 2026 | Agarwala VineetaDirector | Option exercise | 1,333 |
Showing the 12 most recent of 47 compensation filings in this window. The figures above count all of them.
Which funds hold Tenet Healthcare (THC)?
11 of the 45 institutional funds we track reported a Tenet Healthcare position for the quarter ended 30 Jun 2026 — a combined 1.1B USD; the latest of those filings landed 02 Sep 2026.
| Fund | Position | Shares | Value | Shares q/q |
|---|---|---|---|---|
| Glenview Capital Management | Added | 2,235,666 | 418.2M USD | +46.6% |
| Citadel Advisors | Added | 1,765,596 | 330.3M USD | +321.6% |
| AQR Capital Management | Trimmed | 1,067,556 | 198.3M USD | −26.0% |
| Millennium Management | Added | 461,487 | 86.3M USD | +26.5% |
| Point72 Asset Management | New position | 186,987 | 35.0M USD | |
| Marshall Wace | Added | 112,244 | 21.0M USD | +2,161.6% |
| Bridgewater Associates | Added | 42,382 | 7.9M USD | +125.9% |
| Two Sigma Investments | Held (±25%) | 39,497 | 7.4M USD | −2.5% |
| D. E. Shaw & Co. | Trimmed | 30,397 | 5.7M USD | −88.3% |
| Man Group | Trimmed | 6,312 | 1.2M USD | −87.1% |
Showing the 10 largest of 11 reported positions. The figures above count all of them.
Have members of Congress traded Tenet Healthcare (THC)?
The most recent congressional trade disclosed in Tenet Healthcare is a sale by Jonathan L. Jackson (house, IL), dated 15 Apr 2026.
STOCK Act disclosures
| Traded | Member | Type | Amount | Filed after |
|---|---|---|---|---|
| 15 Apr 2026 | Jonathan L. Jacksonhouse · Democrat–IL | Sale | 1K USD–15K USD | 42 days |
| 10 Dec 2025 | Jonathan L. Jacksonhouse · Democrat–IL | Purchase | 15K USD–50K USD | 29 days |
| 03 Sep 2025 | Jonathan L. Jacksonhouse · Democrat–IL | Purchase | 1K USD–15K USD | 42 days |
| 04 Aug 2025 | Lisa C. McClainhouse · Republican–MI | Sale | 1K USD–15K USD | 39 days |
| 11 Jun 2025 | Lisa C. McClainhouse · Republican–MI | Purchase | 1K USD–15K USD | 63 days |
| 04 Sep 2024 | John Jameshouse · Republican–MI | Sale | 1K USD–15K USD | 2 days |
| 10 Nov 2023 | John Jameshouse · Republican–MI | Purchase | 1K USD–15K USD | 297 days |
What has been filed or recorded for Tenet Healthcare (THC)?
The filings we hold for Tenet Healthcare, newest first: 2 fails-to-deliver days, 6 quarterly earnings reports, 2 annual reports and 5 reported financial figures, the latest dated 13 Oct 2026. No next earnings date is announced in SEC filings yet.
| And | ||||
|---|---|---|---|---|
| 13 Oct 2026 | Fails to deliver | Shares failed to deliver | 100 shares | 27K USD notional · <0.001% of shares out |
| 09 Oct 2026 | Fails to deliver | Shares failed to deliver | 1 shares | 261 USD notional · <0.001% of shares out |
| 30 Sep 2026 | Quarterly earnings | Q3 2026 reported | EPS 12.41 USD | |
| 30 Sep 2026 | Financials | Total assets | 31.6B USD | at period end |
| 30 Sep 2026 | Financials | Total equity | 5.4B USD | at period end |
| 30 Jun 2026 | Quarterly earnings | Q2 2026 reported | EPS 9.84 USD | |
| 31 Mar 2026 | Quarterly earnings | Q1 2026 reported | EPS 8.01 USD | |
| 31 Dec 2025 | Annual report | FY 2025 reported | EPS 15.49 USD | |
| 31 Dec 2025 | Financials | Revenue | 21.3B USD | fiscal year |
| 31 Dec 2025 | Financials | Net income to common shareholders | 1.4B USD | fiscal year |
| 31 Dec 2025 | Financials | Diluted EPS | 15.49 USD | fiscal year |
| 30 Sep 2025 | Quarterly earnings | Q3 2025 reported | EPS 3.86 USD | |
| 30 Jun 2025 | Quarterly earnings | Q2 2025 reported | EPS 3.14 USD | |
| 31 Mar 2025 | Quarterly earnings | Q1 2025 reported | EPS 4.27 USD | |
| 31 Dec 2024 | Annual report | FY 2024 reported | EPS 32.70 USD |
Tenet Healthcare (THC): frequently asked questions
What is Tenet Healthcare’s market cap?
Tenet Healthcare is worth 22.6B USD by market value as of 6 Nov 2026, which is the share price times the shares on issue from its SEC filings.
What is Tenet Healthcare’s P/E ratio?
Tenet Healthcare has a price-to-earnings ratio of 8.2, as of 6 Nov 2026: the share price divided by what the company earned per share over the last four reported quarters. A higher number means the market pays more for each dollar of earnings.
What is Tenet Healthcare’s revenue?
Tenet Healthcare reported revenue of 21.3B USD for the year ended 31 Dec 2025, as filed with the SEC. See Filings
Have Tenet Healthcare insiders bought or sold shares recently?
No Tenet Healthcare insider has filed a Form 4 in the last 90 days; the most recent filing we hold is dated 14 Sep 2026 (SEC Form 4). See Insiders
Which funds own Tenet Healthcare?
11 of the 45 funds we track reported a Tenet Healthcare position for the quarter ended 30 Jun 2026, per their SEC Form 13F filings. The largest reported positions were Glenview Capital Management, Citadel Advisors and AQR Capital Management. See Funds
Have members of Congress traded Tenet Healthcare?
Yes. 7 trades in Tenet Healthcare appear in the congressional disclosures we hold; the latest is a sale by Jonathan L. Jackson (House, IL) dated 15 Apr 2026, filed 27 May 2026. Amounts are disclosed as ranges, and a filing can follow the trade by up to 45 days. See Congress
When did Tenet Healthcare last report earnings?
Tenet Healthcare last reported earnings on 30 Sep 2026 for Q3 2026, with EPS of 12.41 USD; no next date is announced in SEC filings yet. See Filings
Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.
References
- Finazonprior-day close, indicative (IEX-derived, not the official close)
- TradingViewthe price chart widget, drawn by TradingView from their own data
- SEC EDGARForm 4 filings (insider transactions)
- SEC EDGAR13F filings
- House disclosuresU.S. House of Representatives financial disclosures
- SECSEC fails-to-deliver (CNS) data
- SEC EDGARXBRL company facts, latest period ended 30 Sep 2026
- SEC EDGARreported earnings figures and scheduled report dates
- SEC EDGARValuation computed from SEC EDGAR filings